A significant breakthrough in the fight against advanced lung cancer has been announced by Dizal, as its innovative drug, ZEGFROVY® (sunvozertinib), has received Accelerated Approval from the U.S. Food and Drug Administration (FDA). This landmark FDA Approval marks ZEGFROVY as the first and only targeted oral treatment specifically designed for […]
Tag: oncology
Chemotherapy can make healthy blood cells ‘look old,’ study suggests
A recent groundbreaking study has unveiled a significant, previously under-explored side effect of chemotherapy: its potential to accelerate the aging process of healthy blood cells, suggesting that while fighting cancer, these vital treatments can inadvertently add decades of “age” to otherwise normal cellular structures. This remarkable discovery prompts a reevaluation […]
Approaches to Risk Stratification, Timing of Treatment Initiation Pose Challenges in Smoldering Myeloma
The complex landscape of smoldering myeloma management continues to challenge oncologists and hematologists, particularly concerning optimal approaches to risk stratification and the precise timing for initiating treatment. As highlighted by Dr. Ajai Chari at the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference, these critical areas remain subjects […]